ONGOING STUDY:
SMAART
SMAART Study
Research Details
About the study: This study is looking at the epidemiology (including features at presentation and the diagnostic and treatment pathway) of severe malaria presenting to hospital for admission in children in Africa today. We hypothesize that there will be differences in the severity spectrum at the 7 sites across 6 countries, that the median age of presentation of paediatric severe malaria is older than historic descriptions and that children will more frequently present with complications that are more typical of the adult form of severe malaria due to the decline in malaria transmission intensity over the last 2 decades. In this study, we aim to characterise the contemporary epidemiology (including features at presentation and the diagnostic and treatment pathway) of severe malaria presenting to hospital for admission in children in Africa, through conducting a prospective multicentre observational study across at least 7 sites in 6 countries, enrolling two cohorts of hospitalised children (i.e. stratified) with severe and non-severe malaria
Objectives
- To compare baseline characteristics of admitted children with severe and non-severe malaria.
- To document time from presentation to the hospital ‘gateway’ (e.g. outpatients or emergency/triage centre) to ward admission and time to first dose of parenteral artesunate to assess whether delays in initiating definitive antimalarial treatment could contribute to malaria severity.
iii. To estimate the incidence of significant post-discharge events to day-180 including readmission (all-cause and for malaria (i.e. relapse)) and all-cause mortality in severe and non-severe malaria.
- To develop (year 1) and evaluate (years 2 and 3) a point-of-care quantitative plasma Plasmodium falciparum histidine-rich protein2 (pfHRP2) test for estimating total body parasite burden, which could be used to swiftly identify those at greatest risk of poor outcomes.
Study Summary
Senior Fellow
Prof. Peter Olupot-Olupot
MB.ChB, MPH, PhD, SRF, FUNAS, FRCP
Study Title: Severe MAlaria A Research and Trials consortium: A protocol for a prospective observational study (SMAART)
REC Approval #: MRRH-2020-10
UNCST Approval #: HS1231ES
Study Duration: 36 months
Sites in Uganda: Soroti RRH and Dr Ambrosini Hospital- Kalongo
Population: Children aged 3month – 15 years with severe malaria
Sample size: 700 children per site
Study Design: Prospective observational case control study